Novartis and GSK vaccines for swine flu get go ahead from EMEA

Friday 25 September 2009

The European Medicines Agency has recommended that two vaccines for influenza A (H1N1), known as swine flu, be granted a European Union-wide marketing authorisation. The vaccines are Focetria from Novartis and Pandemrix from GlaxoSmithKline.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom